Recent Advances in Melanoma Biology

Oncologist

Volumn 9, Issue 2, 2004, Pages 182-187

  Perlis, Cliff ^a   Herlyn, Meenhard ^b  

^a BROWN UNIVERSITY   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Apoptosis; Cell adhesion molecules; Melanoma; Ultraviolet radiation

Indexed keywords

NERVE CELL ADHESION MOLECULE; UVOMORULIN;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CYTOTOXICITY; DISSEMINATED CANCER; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; MELANOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET B RADIATION;

APOPTOSIS; CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; MELANOMA; PROTO-ONCOGENE PROTEINS C-RAF; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 1842556757     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-2-182     Document Type: Review

References (43)

1. Hall HI, Miller DR, Rogers JD et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35-42.
2. Greenlee RT, Hill-Harmon MB, Murray T et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
3. Ries LA, Eisner MP, Kosary CL et al., eds. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD: National Cancer Institute, 2000:Table XVI.
4. Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res 2000;10:81-92.
5. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403-414.
6. Nelemans PJ, Groenendal H, Kiemeney LA et al. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 1993;101:252-255.
7. Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol 1996;25:1132-1138.
8. Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988;58:385-391.
9. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-1662.
10. Freeman SE, Hacham H, Gange RW et al. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989;86:5605-5609.
11. Mitchell DL, Nairn RS. The biology of the (6-4) photoproduct. Photochem Photobiol 1989;49:805-819.
12. Klein-Parker HA, Warshawski L, Tron VA. Melanocytes in human skin express bcl-2 protein. J Cutan Pathol 1994;21:297-301.
13. Plettenberg A, Ballaun C, Pammer J et al. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 1995;146:651-659.
14. Morales-Ducret CR, van de Rijn M, Smoller BR. bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol 1995;131:915-918.
15. Berking C, Takemoto R, Satyamoorthy K et al. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 2001;158:943-953.
16. Ley RD, Applegate LA, Padilla RS et al. Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol 1989;50:1-5.
17. Husain Z, Pathak MA, Flotte T et al. Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation. Cancer Res 1991;51:4964-4970.
18. Setlow RB, Grist E, Thompson K et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993;90:6666-6670.
19. Noonan FP, Recio JA, Takayama H et al. Neonatal sunburn and melanoma in mice. Nature 2001;413:271-272.
20. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 2003;22:3099-3112.
21. Chin L, Pomerantz J, Polsky D et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 1997;11:2822-2834.
22. Kannan K, Sharpless NE, Xu J et al. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci USA 2003;100:1221-1225.
23. Atillasoy ES, Seykora JT, Soballe PW et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am J Pathol 1998;152:1179-1186.
24. Smalley KS. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer 2003;104:527-532.
25. Hingorani SR, Jacobetz MA, Robertson G et al. Suppression of brafv599e in human melanoma abrogates transformation. Cancer Res 2003;63:5198-5202.
26. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954.
27. Brose MS, Volpe P, Feldman M et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 2002;62:6997-7000.
28. Satyamoorthy K, Li G, Gerrero MR et al. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 2003;63:756-759.
29. Satyamoorthy K, Li G, Vaidya B et al. Insulin-like growth factor-1 induces survival and growth in biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res 2001;61:7318-7324.
30. Pollock PM, Harper UL, Hansen KS et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
31. Meier F, Satyamoorthy K, Nesbit M et al. Molecular events in melanoma development and progression. Front Biosci 1998;3:D1005-D1010.
32. Clark WH. Tumour progression and the nature of cancer. Br J Cancer 1991;64:631-644.
33. Danen EH, de Vries TJ, Morandini R et al. E-cadherin expression in human melanoma. Melanoma Res 1996;6:127-131.
34. Xie S, Luca M, Huang S et al. Expression of MCAM/MUC 18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 1997;57:2295-2303.
35. Hsu MY, Wheelock MJ, Johnson KR et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc 1996;1:188-194.
36. Tang A, Eller MS, Hara M et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994;107:983-992.
37. Hsu MY, Meier FE, Nesbit M et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000;156:1515-1525.
38. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001;61:3819-3825.
39. Sturm RA, Satyamoorthy K, Meier F et al. Osteonectin/SPARC induction by ectopic β3 integrin in human radial growth phase primary melanoma cells. Cancer Res 2002;62:226-232.
40. Hsu MY, Shih DT, Meier FE et al. Adenoviral gene transfer of β3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 1998;153:1435-1442.
41. Li G, Kalabis J, Xu X et al. Reciprocal regulation of MelCAM and AKT in melanoma. Oncogene 2003;22:6891-6899.
42. Liu ZJ, Snyder R, Souma A et al. VEGF-A and alphaVbeta3 integrin synergistically rescue angiogenesis via N-Ras and PI3-K signaling in human microvascular endothelial cells. FASEB J 2003;17:1931-1933.
43. Gutheil JC, Campbell TN, Pierce PR et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3. Clin Cancer Res 2000;6:3056-3061.